Role Of Vitamin D In Reproductive Success Following Intra Uterin Insemination In Polycystic Ovary Syndrome Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104216246N1

Enrollment

Registered

2011-09-04

Start date

2011-09-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group : muscular injection of Vitamin D 300000 unit. Intervention 2: Control group: muscular injection of placebo (Our placebo is made using sesame oil, the base componen

Treatment - Drugs

Placebo

Intervention group : muscular injection of Vitamin D 300000 unit

Control group: muscular injection of placebo (Our placebo is made using sesame oil, the base component in vitamin D ampoule)

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All Patients with polycystic Ovary Syndrome who refered to infertility clinic ,candidate for IUI and Vitamin D Level Less than 100ng/ml .exclusion criteria: All Patients with other causes of infertility and patients with Vitamin D Level more than 100ng/ml.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: After14 days of sperm transfer. Method of measurement: B-hcG.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: At the time of fetal heart is seen. Method of measurement: vaginal sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojgan Asadi

Endocrinology& Metabolism Research Center,Tehran University of Medical Sciences

asadim@tums.ac.ir+98 21 8822 0037

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 22, 2026